Statins and diabetes: the good, the bad, and the unknown.

Current atherosclerosis reports

Volumn 15, Issue 2, 2013, Pages

  Axsom, Kelly ^a   Berger, Jeffrey S ^b   Schwartzbard, Arthur Z ^b  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

CARDIOVASCULAR DISEASE; DISEASE COURSE; HEALTH; HUMAN; INSULIN RESISTANCE; METHODOLOGY; MORBIDITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIMARY PREVENTION; REVIEW; RISK FACTOR;

CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; DISEASE PROGRESSION; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INSULIN RESISTANCE; MORBIDITY; PRIMARY PREVENTION; RISK FACTORS; WORLD HEALTH;

EID: 84879525136     PISSN: None     EISSN: 15346242     Source Type: None    
DOI: 10.1007/s11883-012-0299-z     Document Type: Review

References (0)